Rob Fried

Rob Fried is the Chief Executive Officer of ChromaDex, a company that specializes in NAD+ research and nutraceuticals.12 As CEO, Fried has been actively involved in discussing the science and industry developments related to NAD+ and aging.1 He has also been advocating for the formation of an organization consisting of industry leaders to address regulatory challenges in the nutraceutical sector.2

Company Initiatives

Under Fried's leadership, ChromaDex has been involved in several key initiatives:

NAD+ Research:: The company focuses on emerging research related to NAD+ and its potential impact on aging and health.1

Product Development:: ChromaDex recently launched the Niagen+ NAD+ Test Kit, which is exclusively available through the company's channels.3

External Research Program:: Fried has discussed ChromaDex's External Research Program (CERP), highlighting the company's commitment to scientific research.4

Industry Engagement

Rob Fried actively engages with the nutraceutical industry through various channels:

• He has given interviews to industry publications like Nutraceuticals World.1
• Fried has authored op-eds published in Natural Products Insider, addressing regulatory challenges in the industry.2
• He participates in discussions about NAD+ research and its potential applications.13

While specific details about Rob Fried's background are limited in the provided search results, his role as CEO of ChromaDex and his active involvement in the nutraceutical industry are well-documented.